<DOC>
	<DOC>NCT01285557</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of S-1 and Cisplatin compared to 5-FU and Cisplatin in treatment of patients with metastatic diffuse gastric and esophagogastric junction cancer previously untreated with chemotherapy.</brief_summary>
	<brief_title>Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial</brief_title>
	<detailed_description>This is an open-label, international, Phase 3 study evaluating the efficacy and safety of the S-1/cisplatin regimen versus the 5-FU/cisplatin regimen in chemotherapy-na√Øve patients with metastatic diffuse gastric carcinoma including carcinoma of the gastro-esophageal junction. Patients will be randomly assigned to S-1/cisplatin (experimental regimen, Arm A) or 5-FU/cisplatin (control regimen, Arm B).</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Tegafur</mesh_term>
	<criteria>Has given written Informed Consent Histologically confirmed, unresectable, metastatic diffuse gastric cancer including carcinoma of the gastroesophageal junction No prior chemotherapy for gastric cancer except adjuvant and/or neoadjuvant chemotherapy more than 12 months ago Life expectancy of at least 3 months Able to take medications orally ECOG performance status 0 to 1 Adequate organ function (bone marrow, kidney and liver) Certain type(s) of nonmeasurable lesion(s), if the only one(s). Certain serious illness or medical condition(s) Lost greater than or equal to 10% of body weight in the 3 months proceeding signing the ICF Treatment with drugs interacting with S1, 5FU, or cisplatin. Pregnant or lactating female. Known hypersensitivity to fluoropyrimidines or cisplatin. Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Gastric Cancer , S-1, Phase 3</keyword>
</DOC>